Picture of Lucira Health logo

LHDXQ — Lucira Health News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: FDA Authorizes First Single-Use, PCR Quality Over The Counter Lucira Check It Covid-19 At-Home Test

April 12 (Reuters) - Lucira Health Inc  LHDX.O :
    * FDA AUTHORIZES FIRST SINGLE-USE, PCR QUALITY OVER THE
COUNTER
(OTC) LUCIRA CHECK IT™ COVID-19 AT-HOME TEST. AVAILABLE NOW.
    * LUCIRA HEALTH INC -  LUCIRA CHECK IT TEST KIT CAN BE
ORDERED FOR
$55
    * LUCIRA HEALTH INC - EXPECTS NET REVENUE FOR Q1 OF
APPROXIMATELY
$4.0 MILLION TO $4.5 MILLION
    * LUCIRA HEALTH INC -  LUCIRA CHECK IT TEST KIT DELIVERS PCR
QUALITY MOLECULAR ACCURACY IN 30 MINUTES OR LESS AT HOME

Source text for Eikon:  ID:nBw1wCVdBa 
Further company coverage:  LHDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lucira Health

See all news